Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Comprehensive Genomic Profiling of Myeloid Neoplasms: Integrating NGS, Cytogenetics, and FISH for Risk Stratification

AML - 219

Comprehensive Genomic Profiling of Myeloid Neoplasms: Integrating NGS, Cytogenetics, and FISH for Risk Stratification

Zeeshan Ansar Ahmed

Poster Presenter: Zeeshan Ansar Ahmed

Thumbnail for Global Inequities in Leukemia Survival Persist Despite Overall Gains: GBD 2023 MIR Trends, 1990-2023

AML - 222

Global Inequities in Leukemia Survival Persist Despite Overall Gains: GBD 2023 MIR Trends, 1990-2023

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

Previous 1...12 13 14 15 16 17 18...26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 252

Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

Woo Joo Lee

Poster Presenter: Woo Joo Lee

Thumbnail for “EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study"

AML - 256

“EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study"

Juliana Faleschini

Poster Presenter: Juliana Faleschini

Thumbnail for Risk Stratification Using Machine Learning Phenotypes in Acute Myeloblastic Leukemia Patients With Septic Shock

AML - 260

Risk Stratification Using Machine Learning Phenotypes in Acute Myeloblastic Leukemia Patients With Septic Shock

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Venetoclax-Based Therapy Is Associated With Improved Survival in Acute Myeloid Leukemia: A Large Real-World Study

AML - 283

Venetoclax-Based Therapy Is Associated With Improved Survival in Acute Myeloid Leukemia: A Large Real-World Study

Fareeha Abdulwali

Poster Presenter: Fareeha Abdulwali

Thumbnail for Integrating Molecular Profiling To Predict Immunophenotypic MRD Clearance in Acute Myeloid Leukemia

AML - 289

Integrating Molecular Profiling To Predict Immunophenotypic MRD Clearance in Acute Myeloid Leukemia

Ekaterina Motyko

Poster Presenter: Ekaterina Motyko

Thumbnail for Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

AML - 292

Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

Thumbnail for ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML

AML - 296

ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML

Abdelrahman Masheh

Poster Presenter: Abdelrahman Masheh

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors